A personalized approach to the surgical treatment of early-stage uterine body cancer with tumor involvement in the lower uterine segment. Clinical observation

Abstract

In the Russian Federation, the incidence of uterine body cancer remains the highest among malignant neoplasms of the female genital organs. Surgical treatment is the primary method for treating early stages of the disease; however, the issue of predicting metastatic lymph node involvement at the preoperative stage for performing lymphadenectomy remains debatable. The potential prognostic significance of tumor involvement in the lower uterine segment regarding lymph node metastases may justify the need to assess tumor localization before starting treatment. Magnetic resonance imaging (MRI) of the pelvic organs can help determine the involvement of the lower uterine segment in the tumor process, thereby creating a basis for expanding the scope of surgical intervention.

Keywords

• uterine body cancer
• endometrioid adenocarcinoma
• lower uterine segment
• risk factor
• magnetic resonance imaging
• sentinel lymph node
• indocyanine green